The cis-Clopidogrel-MP derivative is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of clopidogrel, a widely prescribed antiplatelet medication. This derivative plays a crucial role in the development of processes aimed at improving the efficiency and yield of clopidogrel production. Researchers focus on optimizing its synthesis to ensure high purity and scalability, which are essential for commercial manufacturing. Additionally, it is studied for its potential in creating analogs or modified versions of clopidogrel, which could offer enhanced therapeutic properties or reduced side effects. Its application is critical in advancing drug development and providing effective treatments for cardiovascular diseases.